KR100583876B1 - 당뇨병 환자의 식이를 위한 참다래 추출물을 함유하는건강기능식품 - Google Patents
당뇨병 환자의 식이를 위한 참다래 추출물을 함유하는건강기능식품 Download PDFInfo
- Publication number
- KR100583876B1 KR100583876B1 KR1020040046646A KR20040046646A KR100583876B1 KR 100583876 B1 KR100583876 B1 KR 100583876B1 KR 1020040046646 A KR1020040046646 A KR 1020040046646A KR 20040046646 A KR20040046646 A KR 20040046646A KR 100583876 B1 KR100583876 B1 KR 100583876B1
- Authority
- KR
- South Korea
- Prior art keywords
- diet
- group
- extract
- diabetic
- weight
- Prior art date
Links
- 235000005911 diet Nutrition 0.000 title abstract description 53
- 230000037213 diet Effects 0.000 title abstract description 46
- 235000001497 healthy food Nutrition 0.000 title 1
- 229940055350 kiwi fruit extract Drugs 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 49
- 239000000284 extract Substances 0.000 claims abstract description 37
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 244000298715 Actinidia chinensis Species 0.000 claims abstract description 7
- 235000009434 Actinidia chinensis Nutrition 0.000 claims abstract description 7
- 208000024891 symptom Diseases 0.000 claims description 12
- 230000036541 health Effects 0.000 claims description 10
- 235000013376 functional food Nutrition 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 230000006872 improvement Effects 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000012669 liquid formulation Substances 0.000 claims description 2
- 235000021055 solid food Nutrition 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims 1
- 235000003434 Sesamum indicum Nutrition 0.000 abstract description 19
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 6
- 244000000231 Sesamum indicum Species 0.000 abstract description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 abstract 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 abstract 1
- 244000077233 Vaccinium uliginosum Species 0.000 abstract 1
- 235000021014 blueberries Nutrition 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 17
- 241000207961 Sesamum Species 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 13
- 241000700159 Rattus Species 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 10
- 229940059463 sesame seed extract Drugs 0.000 description 9
- 230000003247 decreasing effect Effects 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 230000000378 dietary effect Effects 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 235000018823 dietary intake Nutrition 0.000 description 6
- 239000000469 ethanolic extract Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 241000776471 DPANN group Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- -1 synthetic flavors Natural products 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000020880 diabetic diet Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 229940127209 oral hypoglycaemic agent Drugs 0.000 description 1
- 229940125395 oral insulin Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229940119569 wormwood extract Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Abstract
Description
참다래 열매를 잘게 썬 후 분쇄기로 분쇄하여 분말화 한 다음 상기 분말을 각각 열수 또는 에탄올을 사용하여 실온에서 3일 동안 침적시켜 추출하였고, 이 조작을 3회 실시하여 감압 건조한 후 정제하여 분말 형태로 제조하였다.
기본식이는 참다래의 물 또는 에탄올 추출물을 첨가하지 않은 것을 의미하며, 미국영양학회에서 추천하는 AIN-diet(American Institute of Nutrition. 1977. Report of the American Institute of Nutrition Ad Hoc Committee on standards for nutritional studies. Journal of Nutrition, 107:1340~1348.)를 사용하였으며, 그 조성은 표 1에 나타내었다.
성분 | 비율(%) |
카제인 | 20.00 |
옥수수 전분 | 39.75 |
덱스트리화 된 옥수수 전분 | 13.20 |
슈크로즈 | 10.00 |
콩기름 | 7.00 |
셀룰로오즈 | 5.00 |
미네랄 혼합물1) | 3.50 |
비타민 혼합물2) | 1.00 |
L-시스틴 | 0.30 |
콜린 바이타트레이트 | 0.25 |
1) Contained per kg mixture ; CaHPO4 500 g, NaCl 74 g, K3C6O7·H2O 220 g,
K2SO4 52 g, MgO 24 g, 48% Mn 3.5 g, 17% Fe 6.0 g, 70% Zn 1.6 g, 53% Cu 0.3 g, KIO3 0.01 g, CrK(SO4)2·12H2O 0.55 g and sucrose.
2) Contained per kg mixture ; thiamin·HCl 600 mg, riboflavin 600 mg, pyridoxine·HCl
700 mg, nicotinic acid 3 g, Vit. A 400,000 IU (Retinyl acetate), Vit. E (dL-α-tocopheryl acetate) 5,000 IU, Vit. D3 2.5 mg, Vit. K 5.0 mg and sucrose.
실험식이는 상기 기본식이에 실시예 1에서 제조된 에탄올추출물 분말 2.5%(w/w)을 첨가한 실험식이, 기본식이에 실시예 1에서 제조된 열수추출물 분말 5.0%(w/w)을 첨가한 실험식이, 생수에 기본식이 및 실시예 1에서 제조된 에탄올추출물 분말 2.0%(w/w)을 첨가한 음료용 실험식이 및 생수에 기본식이 및 실시예 1에서 제조된 에탄올추출물 분말 2.0%(w/w)을 첨가한 음료용 실험식이를 제조하였다.
B군 : 기본식이에 실시예 1에서 제조된 에탄올추출물 분말 5.0%(w/w)를 첨가한 실험식이를 투여한 당뇨유발 쥐 투여군
C군 : 생수에 기본식이 및 실시예 1에서 제조된 열수추출물 분말 2.0%(w/w)를 첨가한 음료용 실험식이를 투여한 당뇨유발 쥐 투여군
D군 : 생수에 기본식이 및 실시예 1에서 제조된 에탄올추출물 분말 2.0%(w/w)를 첨가한 음료용 실험식이를 투여한 당뇨유발 쥐 투여군
E군 : 기본식이를 투여한 당뇨유발 쥐 투여군(당뇨대조군)
F군 : 기본식이를 투여한 당뇨를 유발시키지 않은 쥐 투여군(일반대조군)
상기 투여군에 대한 참다래 추출물의 시험배치를 표 2로 나타내었다.
본 실험에서 알 수 있는 바와 같이, 참다래의 추출물시료(Diet, Drink)를 급여한 당뇨유발 쥐(A, B, C, D)는 혈당농도 감소 효과가 우수하였으며, 특히 당뇨군의 경우 참다래식이군(A, B)이 참다래음료군(C, D)에 비해 기준혈당에 비해 혈당치 감소가 현저히 높았다(표 8).
Claims (4)
- 당뇨병 증상의 개선을 위한 참다래(Actinidia Chinensis) 열매 추출물 함유 건강기능식품.
- 제 1 항에 있어서, 상기 건강기능식품은 고상식품인 것을 특징으로 하는 당뇨병 증상의 개선을 위한 참다래(Actinidia Chinensis) 열매 추출물 함유 건강기능식품.
- 제 1 항에 있어서, 상기 건강기능식품은 음료 또는 다류 임을 특징으로 하는 당뇨병 증상의 개선을 위한 참다래(Actinidia Chinensis) 열매 추출물 함유 건강기능식품.
- 제 1항에 있어서, 상기 식품은 투여형태가 정제, 과립제, 캅셀제 또는 액제 제형 중에서 선택됨을 특징으로 하는 당뇨병 증상의 개선을 위한 참다래(Actinidia Chinensis) 열매 추출물 함유 건강기능식품.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040046646A KR100583876B1 (ko) | 2004-06-22 | 2004-06-22 | 당뇨병 환자의 식이를 위한 참다래 추출물을 함유하는건강기능식품 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040046646A KR100583876B1 (ko) | 2004-06-22 | 2004-06-22 | 당뇨병 환자의 식이를 위한 참다래 추출물을 함유하는건강기능식품 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050121493A KR20050121493A (ko) | 2005-12-27 |
KR100583876B1 true KR100583876B1 (ko) | 2006-05-26 |
Family
ID=37293637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040046646A KR100583876B1 (ko) | 2004-06-22 | 2004-06-22 | 당뇨병 환자의 식이를 위한 참다래 추출물을 함유하는건강기능식품 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100583876B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101342497B1 (ko) | 2012-04-25 | 2013-12-17 | 대구한의대학교산학협력단 | 알파-글루코시다아제 저해활성을 가지는 다래나무 줄기추출물 및 이를 함유하는 혈당강하용 조성물 |
KR20180023859A (ko) * | 2016-08-26 | 2018-03-07 | 경상대학교산학협력단 | 다래 추출물 또는 이의 분획물을 유효성분으로 포함하는 당뇨 또는 당뇨합병증 예방 또는 치료용 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960016781A (ko) * | 1994-11-23 | 1996-06-17 | 까뜨리오나 프란세스 마르 | 영양이 보강된 과일 쥬스 |
JP2002338485A (ja) | 2001-05-22 | 2002-11-27 | Hideko Iizuka | 病気の治療の為のジュースの作り方 |
-
2004
- 2004-06-22 KR KR1020040046646A patent/KR100583876B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960016781A (ko) * | 1994-11-23 | 1996-06-17 | 까뜨리오나 프란세스 마르 | 영양이 보강된 과일 쥬스 |
JP2002338485A (ja) | 2001-05-22 | 2002-11-27 | Hideko Iizuka | 病気の治療の為のジュースの作り方 |
Non-Patent Citations (2)
Title |
---|
2002년 |
WO2003103415 A1 ERROR |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101342497B1 (ko) | 2012-04-25 | 2013-12-17 | 대구한의대학교산학협력단 | 알파-글루코시다아제 저해활성을 가지는 다래나무 줄기추출물 및 이를 함유하는 혈당강하용 조성물 |
KR20180023859A (ko) * | 2016-08-26 | 2018-03-07 | 경상대학교산학협력단 | 다래 추출물 또는 이의 분획물을 유효성분으로 포함하는 당뇨 또는 당뇨합병증 예방 또는 치료용 조성물 |
KR101942959B1 (ko) | 2016-08-26 | 2019-01-28 | 경상대학교산학협력단 | 다래 추출물 또는 이의 분획물을 유효성분으로 포함하는 당뇨 또는 당뇨합병증 예방 또는 치료용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20050121493A (ko) | 2005-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2011500B1 (en) | Fat accumulation inhibitor for the treatment of metabolic syndrome | |
CN108420854B (zh) | 提高耐力表现的抗疲劳组合物 | |
EP1932533A1 (en) | Composition for amelioration of body lipid | |
KR101976941B1 (ko) | 토종 보리수 추출물을 포함하는 당뇨병 예방 및 치료용 조성물 | |
KR101616811B1 (ko) | 짚신나물 추출물을 유효성분으로 포함하는 당뇨 및 당뇨합병증 예방 또는 개선용 조성물 | |
KR102348044B1 (ko) | 번아웃증후군의 예방, 개선 또는 치료용 조성물 | |
KR20100088794A (ko) | 새송이버섯 추출물을 유효성분으로 함유하는 제 2형 당뇨병에 의한 지질대사 장애 및 당뇨합병증 질환의 예방 및 치료용 조성물 | |
KR100583876B1 (ko) | 당뇨병 환자의 식이를 위한 참다래 추출물을 함유하는건강기능식품 | |
KR101775087B1 (ko) | 멀베로푸란 g, 상게논 g 및 상게놀 a를 유효성분으로 함유하는 스트레스 또는 우울 증상의 개선, 예방 또는 치료용 조성물 | |
KR102239066B1 (ko) | 식물 추출물의 혼합물을 유효성분으로 함유하는 대사성 질환의 예방, 개선 또는 치료용 조성물 | |
KR20120082196A (ko) | 혈액의 조성 및 기능 회복 효과를 갖는 기능성 식품용 조성물 | |
KR20150031373A (ko) | 비타민나무 잎 추출물을 유효성분으로 함유하는 비만 예방 또는 치료용 약학 조성물 및 식품 조성물 | |
KR101071511B1 (ko) | 마늘 당절임 추출물을 유효성분으로 함유하는 혈당강하 또는 당뇨병의 예방 및 치료용 조성물 | |
CN105106721A (zh) | 一种具有降糖功效的保健品 | |
KR101147913B1 (ko) | 혈당 조절용 조성물 | |
KR20050003665A (ko) | 식방풍 추출물을 포함하는 당뇨병 예방 및 치료를 위한조성물 | |
KR100535322B1 (ko) | 부추 추출물을 유효성분으로 함유하는 당뇨 질환의 예방및 치료용 약학 조성물 | |
KR101355830B1 (ko) | 알릴이소시아네이트를 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학 조성물 및 건강기능식품 | |
KR20140147482A (ko) | 용담 추출물의 분획물을 유효성분으로 포함하는 당뇨병 전증 또는 당뇨병의 예방 또는 치료용 조성물 | |
CN110404029B (zh) | 一种具有降血糖功效的组合物及其制备方法和应用 | |
KR20180006535A (ko) | 산수유 추출물을 유효성분으로 포함하는 당뇨병 예방 또는 치료용 조성물 | |
KR20150031372A (ko) | 비타민나무 열매 추출물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학 조성물 및 식품 조성물 | |
KR100918488B1 (ko) | 단풍나무 수액을 포함하는 혈당수준 개선용 식품 | |
KR20070099056A (ko) | 당뇨병 및/또는 당뇨병성 신증의 예방, 개선, 또는 치료용조성물 | |
KR101074521B1 (ko) | 혈당강하 효능을 갖는 천연 칼슘 화합물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121128 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20131127 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20141208 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161123 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180104 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190103 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20200107 Year of fee payment: 15 |